2005 Annual Meeting | Update of Neuromuscular Disease

Date Saturday 04/09/05

Time 06:00 PM - 08:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Stacy A. Rudnicki, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Upon completion:
Participants should become familiar with neuromuscular paraneoplastic disorders, recent advances in ALS, and immunotherapy used in the treatment of neuromuscular diseases.

The American Board of Psychiatry and Neurology has reviewed Update in Neuromuscular Disease and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:00 PM - 06:35 PM		What's New in ALS Stacy A. Rudnicki, MD, FAAN
06:00 PM - 08:00 PM		Refreshments
06:35 PM - 07:10 PM		Immune-Mediated Paraneoplastic Syndromes with Involvement of the Peripheral Nervous System Josep O. Dalmau, MD, PhD, FAAN
07:10 PM - 07:45 PM		Immunotherapy in the Treatment of Neuromuscular Diseases James A. Russell, DO, FAAN
07:45 PM - 08:00 PM		Questions and Answers

Faculty Disclosures
Stacy A. Rudnicki, MD, FAAN	Dr. Rudnicki has received personal compensation for serving as an employee of Cytokinetics. Dr. Rudnicki has stock in Cytokinetics.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
James A. Russell, DO, FAAN	Dr. Russell has received publishing royalties from a publication relating to health care.